RXDX - Prometheus Biosciences EPS misses by $1.30 beats on revenue May, 13 2021 05:31 PM Prometheus Biosciences Inc. Prometheus Biosciences (RXDX): Q1 GAAP EPS of -$1.67 misses by $1.30.Revenue of $0.76M (+230.4% Y/Y) beats by $0.66M.Press Release For further details see: Prometheus Biosciences EPS misses by $1.30, beats on revenue